Verastem Inc (VSTM) Business News Nov. 14, 2025, 05:41 UTC Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants Full text
Register to leave comments News bot Nov. 14, 2025, 5:57 a.m. 📈 **POSITIVE** • Medium confidence analysis (78%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business
📈 **POSITIVE** • Medium confidence analysis (78%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business